201 related articles for article (PubMed ID: 368816)
1. Reversal of digitalis effects by specific antibodies.
Larbig D; Raff U; Haasis R
Pharmacology; 1979; 18(1):1-8. PubMed ID: 368816
[TBL] [Abstract][Full Text] [Related]
2. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
Smith TW; Butler VP; Haber E; Fozzard H; Marcus FI; Bremner WF; Schulman IC; Phillips A
N Engl J Med; 1982 Nov; 307(22):1357-62. PubMed ID: 6752715
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
Smith TW; Lloyd BL; Spicer N; Haber E
Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
[TBL] [Abstract][Full Text] [Related]
4. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
Antman EM; Wenger TL; Butler VP; Haber E; Smith TW
Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752
[TBL] [Abstract][Full Text] [Related]
5. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.
Butler VP; Schmidt DH; Smith TW; Haber E; Raynor BD; Demartini P
J Clin Invest; 1977 Feb; 59(2):345-59. PubMed ID: 299860
[TBL] [Abstract][Full Text] [Related]
6. [Immunopharmacologic treatment of 9 digitalis poisonings in children with sheep antidigoxin Fab].
Smolarz A; Abshagen U
Monatsschr Kinderheilkd; 1985 Sep; 133(9):682-7. PubMed ID: 4058431
[TBL] [Abstract][Full Text] [Related]
7. Digoxin specific antibody (Fab) fragments in 34 cases of severe digitalis intoxication.
Smolarz A; Roesch E; Lenz E; Neubert H; Abshagen P
J Toxicol Clin Toxicol; 1985; 23(4-6):327-40. PubMed ID: 4057323
[TBL] [Abstract][Full Text] [Related]
8. [Fab fragments of antidigoxin antibodies and acute digitalis poisoning].
Tribouilloy C; Vovan A; Isorni C; Castier B; Lesbre JP
Ann Cardiol Angeiol (Paris); 1986 Oct; 35(8):469-73. PubMed ID: 3813453
[TBL] [Abstract][Full Text] [Related]
9. Comparison of non-digitalis binding properties of digoxin-specific Fabs using direct binding methods.
Pullen MA; Harpel MR; Danoff TM; Brooks DP
J Immunol Methods; 2008 Jul; 336(2):235-41. PubMed ID: 18555269
[TBL] [Abstract][Full Text] [Related]
10. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments.
Wenger TL; Butler VP; Haber E; Smith TW
J Am Coll Cardiol; 1985 May; 5(5 Suppl A):118A-123A. PubMed ID: 3886748
[TBL] [Abstract][Full Text] [Related]
11. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
Wenger TL
Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
[TBL] [Abstract][Full Text] [Related]
12. [Severe poisoning with digitalis treated by the administration of anti-digoxin antibodies].
Delgado Jiménez JF; Casillas Villamor A; Gómez Pajuelo C; Sáenz de la Calzada C
Rev Clin Esp; 1991 Nov; 189(8):374-6. PubMed ID: 1784800
[TBL] [Abstract][Full Text] [Related]
13. Use of digoxin-specific Fab fragments in the treatment of digitalis intoxication.
Cole PL; Smith TW
Drug Intell Clin Pharm; 1986 Apr; 20(4):267-70. PubMed ID: 3698816
[TBL] [Abstract][Full Text] [Related]
14. Digitalis pharmacokinetics and metabolism.
Marcus FI
Am J Med; 1975 Apr; 58(4):452-9. PubMed ID: 1092160
[TBL] [Abstract][Full Text] [Related]
15. Digoxin and digoxin derivative induced arrhythmias: in vitro binding and in vivo abolition of arrhythmias by digoxin immune Fab (DIGIBAND).
Cambridge D; Morgan CR; Allen G
Cardiovasc Res; 1992 Sep; 26(9):906-11. PubMed ID: 1451168
[TBL] [Abstract][Full Text] [Related]
16. Results of multicenter studies of digoxin-specific antibody fragments in managing digitalis intoxication in the pediatric population.
Woolf AD; Wenger TL; Smith TW; Lovejoy FH
Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):16-20; discussion 33-4. PubMed ID: 1997016
[TBL] [Abstract][Full Text] [Related]
17. [Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
Domart Y; Bismuth C; Schermann JM; Abuaf N; Pontal PG; Baud F; Bolo A; Gailliot M; Fournier PE
Nouv Presse Med; 1982 Dec; 11(52):3827-30. PubMed ID: 7162976
[TBL] [Abstract][Full Text] [Related]
18. Immunological reversal of the effects of digoxin.
Butler VP; Smith TW; Schmidt DH; Haber E
Fed Proc; 1977 Aug; 36(9):2235-41. PubMed ID: 142027
[No Abstract] [Full Text] [Related]
19. The stimulatory effect on human erythrocyte rubidium-86 uptake by anti-cardiac-glycoside antibodies.
Balzan S; Montali U; Pieraccini L; Di Bartolo V; Pegoraro S; Revoltella R; Ghione S
Q J Nucl Med; 1995 Jun; 39(2):134-9. PubMed ID: 8574808
[TBL] [Abstract][Full Text] [Related]
20. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
Ochs HR; Smith TW
J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
